These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1975080)

  • 1. H1 antihistamines interact with central sigma receptors.
    Gray NM; Contreras PC; Allen SE; Taylor DP
    Life Sci; 1990; 47(2):175-80. PubMed ID: 1975080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the mechanism by which sigma ligands inhibit stimulation of phosphoinositide metabolism by muscarinic cholinergic agonists.
    Bowen WD; Tolentino P; Varghese P
    Prog Clin Biol Res; 1990; 328():21-4. PubMed ID: 2154780
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro antagonism of benzodiazepine binding to cerebral receptors by H1 and H2 antihistamines.
    Speeg KV; Wang S; Avant GR; Parker R; Schenker S
    J Lab Clin Med; 1981 Jan; 97(1):112-2. PubMed ID: 6108979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M1 muscarinic antagonists interact with sigma recognition sites.
    Hudkins RL; DeHaven-Hudkins DL
    Life Sci; 1991; 49(17):1229-35. PubMed ID: 1658507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Specific binding of N-allylnormetazocine (SKF 10047), a ligand of sigma-opioid receptors, with liver membranes].
    Samovilova NN; Iarygin KN; Vinogradov VA
    Bioorg Khim; 1985 Oct; 11(10):1380-4. PubMed ID: 3000388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of sigma-receptors: high- and low-affinity agonist states, GTP shifts, and up-regulation by rimcazole and 1,3-Di(2-tolyl)guanidine.
    Beart PM; O'Shea RD; Manallack DT
    J Neurochem; 1989 Sep; 53(3):779-88. PubMed ID: 2569504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of H2-antihistamines in murine models of immediate hypersensitivity and chronic inflammation.
    Kaneta S; Yanaguimoto H; Kagaya J; Ishizuki S; Fujihira E
    Res Commun Chem Pathol Pharmacol; 1993 Feb; 79(2):167-84. PubMed ID: 8095732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of sigma receptors and responsiveness to guanine nucleotides following repeated exposure of rats to haloperidol: further evidence for multiple sigma binding sites.
    Itzhak Y; Stein I
    Brain Res; 1991 Dec; 566(1-2):166-72. PubMed ID: 1667608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GBR-12909 and fluspirilene potently inhibited binding of [3H] (+)3-PPP to sigma receptors in rat brain.
    Contreras PC; Bremer ME; Rao TS
    Life Sci; 1990; 47(22):PL133-7. PubMed ID: 1980329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and behavioral effects of sigma and PCP ligands.
    Contreras PC; Contreras ML; O'Donohue TL; Lair CC
    Synapse; 1988; 2(3):240-3. PubMed ID: 2850629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ifenprodil and SL 82.0715 potently inhibit binding of [3H](+)-3-PPP to sigma binding sites in rat brain.
    Contreras PC; Bremer ME; Gray NM
    Neurosci Lett; 1990 Aug; 116(1-2):190-3. PubMed ID: 1979666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of [3H](-)-SKF-10,047 with brain sigma receptors: characterization and autoradiographic visualization.
    Zukin SR; Tempel A; Gardner EL; Zukin RS
    J Neurochem; 1986 Apr; 46(4):1032-41. PubMed ID: 3005501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histamine agonist and antagonist drugs: interference with CNS control of GH release in rats.
    Netti C; Guidobono F; Olgiati VR; Sibilia V; Pecile A
    Horm Res; 1981; 14(3):180-91. PubMed ID: 6116658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related differences in the sensitivity of rats to a selective sigma ligand.
    Matsumoto RR; Bowen WD; Walker JM
    Brain Res; 1989 Dec; 504(1):145-8. PubMed ID: 2557123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. sigma receptors in rat brain and testes show similar reductions in response to chronic haloperidol.
    Jansen KL; Elliot M; Leslie RA
    Eur J Pharmacol; 1992 Apr; 214(2-3):281-3. PubMed ID: 1325359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y and peptide YY interact with rat brain sigma and PCP binding sites.
    Roman FJ; Pascaud X; Duffy O; Vauche D; Martin B; Junien JL
    Eur J Pharmacol; 1989 Dec; 174(2-3):301-2. PubMed ID: 2560982
    [No Abstract]   [Full Text] [Related]  

  • 17. Sigma binding sites in the brain; an emerging concept for multiple sites and their relevance for psychiatric disorders.
    Itzhak Y; Stein I
    Life Sci; 1990; 47(13):1073-81. PubMed ID: 2172677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of sigma receptors by chronic haloperidol.
    Matsumoto RR; Bowen WD; Walker JM
    Prog Clin Biol Res; 1990; 328():125-8. PubMed ID: 2154764
    [No Abstract]   [Full Text] [Related]  

  • 19. H2 histaminic receptors in rat cerebral cortex. 2. Inhibition of [3H]histamine by H2 antagonists.
    Steinberg GH; Kandel M; Kandel SI; Wells JW
    Biochemistry; 1985 Oct; 24(22):6107-15. PubMed ID: 2867776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs.
    Weber E; Sonders M; Quarum M; McLean S; Pou S; Keana JF
    Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8784-8. PubMed ID: 2877462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.